www.fdanews.com/articles/199161-vida-diagnostics-deep-learning-algorithm-gets-fda-clearance
![VIDADiagnosticsLogo-430x250.png](https://www.fdanews.com/ext/resources/test/Device_Images6/VIDADiagnosticsLogo-430x250.png?t=1600727320&width=430)
VIDA Diagnostics’ Deep Learning Algorithm Gets FDA Clearance
September 22, 2020
The FDA has granted 510(k) clearance for VIDA Diagnostics’ VIDA algorithm, artificial intelligence-based (AI) software that analyzes lung scans.
The algorithm is an addition to the company’s LungPrint suite that helps to improve lung- imaging assessments by including disease probability and progression.
The AI-powered analysis “empowers physicians to develop personalized treatment plans that can improve outcomes and quality of life,” the company said.